Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer

Overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is critical in combating EGFR-mutant non-small cell lung cancer (NSCLC). We tried to construct a novel therapeutic strategy to conquer the resistance to second-and third-generation EGFR-TKIs in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Rep
Autori principali: Takahashi, Akiko, Seike, Masahiro, Chiba, Mika, Takahashi, Satoshi, Nakamichi, Shinji, Matsumoto, Masaru, Takeuchi, Susumu, Minegishi, Yuji, Noro, Rintaro, Kunugi, Shinobu, Kubota, Kaoru, Gemma, Akihiko
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173712/
https://ncbi.nlm.nih.gov/pubmed/30291293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-33190-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi